Matches in Wikidata for { <http://www.wikidata.org/entity/Q92169116> ?p ?o ?g. }
Showing items 1 to 65 of
65
with 100 items per page.
- Q92169116 description "artículu científicu espublizáu n'avientu de 2019" @default.
- Q92169116 description "scientific article published on 19 December 2019" @default.
- Q92169116 description "wetenschappelijk artikel" @default.
- Q92169116 description "наукова стаття, опублікована 19 грудня 2019" @default.
- Q92169116 name "Oxyberberine, a novel gut microbiota-mediated metabolite of berberine, possesses superior anti-colitis effect: Impact on intestinal epithelial barrier, gut microbiota profile and TLR4-MyD88-NF-κB pathway" @default.
- Q92169116 name "Oxyberberine, a novel gut microbiota-mediated metabolite of berberine, possesses superior anti-colitis effect: Impact on intestinal epithelial barrier, gut microbiota profile and TLR4-MyD88-NF-κB pathway" @default.
- Q92169116 type Item @default.
- Q92169116 label "Oxyberberine, a novel gut microbiota-mediated metabolite of berberine, possesses superior anti-colitis effect: Impact on intestinal epithelial barrier, gut microbiota profile and TLR4-MyD88-NF-κB pathway" @default.
- Q92169116 label "Oxyberberine, a novel gut microbiota-mediated metabolite of berberine, possesses superior anti-colitis effect: Impact on intestinal epithelial barrier, gut microbiota profile and TLR4-MyD88-NF-κB pathway" @default.
- Q92169116 prefLabel "Oxyberberine, a novel gut microbiota-mediated metabolite of berberine, possesses superior anti-colitis effect: Impact on intestinal epithelial barrier, gut microbiota profile and TLR4-MyD88-NF-κB pathway" @default.
- Q92169116 prefLabel "Oxyberberine, a novel gut microbiota-mediated metabolite of berberine, possesses superior anti-colitis effect: Impact on intestinal epithelial barrier, gut microbiota profile and TLR4-MyD88-NF-κB pathway" @default.
- Q92169116 P1433 Q92169116-B682ACFE-7F85-4E86-8D96-8764BE44FDC0 @default.
- Q92169116 P1476 Q92169116-26F69B4F-77B0-41E8-BF27-0C0B9402A6BD @default.
- Q92169116 P2093 Q92169116-0C9AA9C3-50B7-4B90-BAD4-B5D3EEDB94AC @default.
- Q92169116 P2093 Q92169116-2E55CA94-1E0E-4F24-AB2B-5D55AA43106A @default.
- Q92169116 P2093 Q92169116-383B5E6C-6279-435A-8D6D-8704A879C9BB @default.
- Q92169116 P2093 Q92169116-41143467-81EC-4600-8D0F-67B0840D97FC @default.
- Q92169116 P2093 Q92169116-6DF18AD6-5489-4303-A829-B14DBC76E2C0 @default.
- Q92169116 P2093 Q92169116-88B88E02-BBE5-4F2C-8E5B-9AAA46645B5A @default.
- Q92169116 P2093 Q92169116-8E1236D3-C06B-404D-BE28-3B567D515F35 @default.
- Q92169116 P2093 Q92169116-90231525-8CFB-4B93-AE99-1207649D9EA0 @default.
- Q92169116 P2093 Q92169116-93B3C119-1E5B-4346-A976-67556C667610 @default.
- Q92169116 P2093 Q92169116-9852F743-545C-4FAE-8525-D19821F46CBE @default.
- Q92169116 P2093 Q92169116-A80FE430-B610-46DF-B72C-9D63851DF77A @default.
- Q92169116 P2093 Q92169116-A8AB6407-AE2F-424F-90E6-72EF77628BB7 @default.
- Q92169116 P2093 Q92169116-B1A51C8F-45B8-4FD6-8C7F-56AF81636A14 @default.
- Q92169116 P2093 Q92169116-B894F71C-84B7-4ABF-8244-D9F00AE4E417 @default.
- Q92169116 P2093 Q92169116-CBBBB107-7738-4DEC-B08D-524A65CB9360 @default.
- Q92169116 P2093 Q92169116-E3616DB2-3662-4B81-ACCD-5D0CCF164202 @default.
- Q92169116 P2860 Q92169116-F6E5FD53-191B-4793-B828-FB9F3502307C @default.
- Q92169116 P304 Q92169116-5A33F1ED-27B0-45D6-B352-3E561E6448F4 @default.
- Q92169116 P31 Q92169116-6104BDA4-1F14-4F3D-9742-5362CBD96327 @default.
- Q92169116 P356 Q92169116-37A9D8AE-19AC-48DE-BA29-2412F0669813 @default.
- Q92169116 P478 Q92169116-30484A6A-D5A3-4D36-8F8D-FE403E505667 @default.
- Q92169116 P577 Q92169116-D8B3DF75-F37A-45A1-A5E0-80798BB13C5F @default.
- Q92169116 P698 Q92169116-CC82A06F-0992-4A9D-B1B1-AF1CB1028E1B @default.
- Q92169116 P921 Q92169116-0A348EEA-5E7C-4BEA-80A7-47B04F3452F1 @default.
- Q92169116 P356 J.PHRS.2019.104603 @default.
- Q92169116 P698 31863867 @default.
- Q92169116 P1433 Q15724622 @default.
- Q92169116 P1476 "Oxyberberine, a novel gut microbiota-mediated metabolite of berberine, possesses superior anti-colitis effect: Impact on intestinal epithelial barrier, gut microbiota profile and TLR4-MyD88-NF-κB pathway" @default.
- Q92169116 P2093 "Cailan Li" @default.
- Q92169116 P2093 "Chaodan Luo" @default.
- Q92169116 P2093 "Gaoxiang Ai" @default.
- Q92169116 P2093 "Guosheng Lin" @default.
- Q92169116 P2093 "Huifang Zeng" @default.
- Q92169116 P2093 "Jianhui Xie" @default.
- Q92169116 P2093 "Jiannan Chen" @default.
- Q92169116 P2093 "Lihua Tan" @default.
- Q92169116 P2093 "Qiang Lu" @default.
- Q92169116 P2093 "Xiaoqi Huang" @default.
- Q92169116 P2093 "Yanfang Xian" @default.
- Q92169116 P2093 "Yongfu Wang" @default.
- Q92169116 P2093 "Yucui Li" @default.
- Q92169116 P2093 "Yuhong Liu" @default.
- Q92169116 P2093 "Zhixiu Lin" @default.
- Q92169116 P2093 "Ziren Su" @default.
- Q92169116 P2860 Q92491606 @default.
- Q92169116 P304 "104603" @default.
- Q92169116 P31 Q13442814 @default.
- Q92169116 P356 "10.1016/J.PHRS.2019.104603" @default.
- Q92169116 P478 "152" @default.
- Q92169116 P577 "2019-12-19T00:00:00Z" @default.
- Q92169116 P698 "31863867" @default.
- Q92169116 P921 Q411114 @default.